Children's Cancer Group (CCG) initiatives in childhood acute lymphoblastic leukemia

International Journal of Pediatric Hematology/Oncology

Volumn 5, Issue 2-4, 1998, Pages 99-114

  Gaynon, P S ^a   Bostrom, B C ^a   Reaman, G H ^a   Sather, H N ^a   Trigg, M E ^a   Tubergen, D G ^a   Uckun, F M ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Childhood acute lymphoblastic leukemia; Early response to therapy; Postinduction intensification

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ASPARAGINASE; B43 PAP; CD19 ANTIGEN; CYCLOHEXIMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOTOXIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD LEUKEMIA; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0031854025     PISSN: 10702903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)